May 10, 2018 / 11:15 AM / 6 months ago

BRIEF-Cipher Pharmaceuticals Q1 Loss Per Share $0.04 From Continuing Operations

May 10 (Reuters) - Cipher Pharmaceuticals Inc:

* Q1 REVENUE $4.6 MILLION VERSUS $8.1 MILLION

* EXPECTS TO ADD SIX NEW PRODUCTS FROM ITS EXISTING PIPELINE TO ITS CANADIAN COMMERCIAL PORTFOLIO IN 2018 AND 2019

* CONTINUES TO PURSUE NEW IN-LICENSING OPPORTUNITIES AND ACQUISITIONS TO FURTHER EXPAND ITS NEAR-TERM PRODUCT PIPELINE

* EXPECTS ITS GLOBAL LICENSING BUSINESS TO PROVIDE A “SOLID BASE” OF HIGH-MARGIN ROYALTY REVENUE IN 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below